Review of the molecular pathogenesis of osteosarcoma

Jin-Peng He1, Yun Hao, Xiao-Lin Wang

  • 1Pediatric Surgery Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China E-mail : olang@foxmail.com, hejinpeng2006@126.com.

Insights

Osteosarcoma (OSA) treatment is challenging, especially for metastatic cases. Understanding OSA

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Osteosarcoma (OSA) presents significant treatment challenges, particularly for metastatic disease.
  • Current therapeutic strategies primarily target the primary tumor, showing limited effectiveness against widespread OSA.
  • A deeper comprehension of OSA's molecular underpinnings is crucial for developing novel treatments.

Purpose of the Study:

  • To review the molecular mechanisms driving osteosarcoma (OSA) tumorigenesis.
  • To explore the molecular pathways involved in OSA cell proliferation, apoptosis, migration, and chemotherapy resistance.
  • To identify potential therapeutic targets for OSA based on a comprehensive understanding of its pathogenesis.

Main Methods:

  • Literature review of molecular mechanisms in osteosarcoma (OSA).
  • Analysis of studies on OSA cell proliferation, apoptosis, migration, and drug resistance.
  • Synthesis of current knowledge on OSA pathogenesis and therapeutic targets.

Main Results:

  • Detailed overview of molecular mechanisms in osteosarcoma (OSA) development and progression.
  • Identification of key pathways regulating OSA cell behavior and treatment response.
  • Highlighting the need for targeted therapies addressing metastatic OSA.

Conclusions:

  • A thorough understanding of osteosarcoma (OSA) molecular pathogenesis is essential for advancing treatment strategies.
  • Targeting specific molecular pathways offers promise for improving outcomes in metastatic OSA.
  • Further research into OSA's molecular biology can guide the development of more effective therapies.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Progression02:07

Tumor Progression

3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K